SAM #140D0426Q0322

Sole Source Procurement of Illumina MiSeq i100 Plus Sequencing System for NCI Genomics Core

This opportunity involves the sole source procurement of an Illumina MiSeq i100 Plus Sequencing System for the National Cancer Institute's Center for Cancer Research Genomics Core. - The Department of the Interior's Interior Business Center is managing the acquisition - Illumina, Inc. is the only OEM specified and is considered the sole source provider - The procurement includes: - One Illumina MiSeq i100 Plus Sequencing System - Delivery, installation, and training services - The system will replace aging sequencing instruments and support centralized sequencing operations - Delivery must be completed within 12 weeks after contract award - Place of performance is the CCR Genomics Core, National Cancer Institute, Bethesda, MD - Contracting office is located in Herndon, VA - No competing OEMs or alternative products are mentioned; however, similar sequencing systems from Thermo Fisher Scientific or Pacific Biosciences could be considered alternatives in other contexts - Estimated contract value is likely in the $50,000–$150,000 range based on typical pricing for similar systems and services

Description

Illumina MiSeq i100 Series system

View original listing